Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
| Time | Room 1 (Vista 1+2) |
Room 2 (Grand 1) |
Room 3 (Walker 1) |
Room 4 (Walker 2) |
Room 5 (Art Hall) |
| 07:30-08:15 |
Satellite Symposium 3
|
||||
|---|---|---|---|---|---|
| 08:15-08:30 | Break | ||||
| 08:30-09:45 |
Symposium 5
Biomarker-Driven Adaptive Surgery
|
Panel Discussion 4
Current Landscapes and Future Prospectives of HER2 low/ultralow Breast Cancer
|
Symposium 6
AI Across Breast Imaging
|
Nursing Session 1 (Kor.)
From Surgery to Systemic Therapy: Managing Physical Complication in Breast Cancer Care
|
Mini Oral Presentation 3
|
| 09:45-10:00 | Break | ||||
| 10:00-11:15 |
General Session 2
|
Multidisciplinary Session
Integrating AI into Cancer Treatment
|
Education Session 2
Modern Axillary Care in Breast Cancer: Integrating Surgical, Imaging and Pathologic Insights
|
Nursing Session 2 (Kor.)
Unmet Needs and Holistic Care in Patient with Metastatic or Recurrent Breast Cancer
|
GBCC-JBCS-TBCS Joint Session
Current Evidence of Ovarian Function Suppression and Real-World Practice in Asia
|
| 11:15-11:30 | Break | ||||
| 11:30-12:15 |
Plenary Lecture 3
Next Generation ADCs
|
||||
| 12:15-12:30 | Break | ||||
| 12:30-13:15 |
Satellite Symposium 4
|
Satellite Symposium 5
|
|||
| 13:15-13:30 | Break | ||||
| 13:30-14:15 |
Plenary Lecture 4
What Does it Take to Make Precision Oncology Precise?
|
||||
| 14:15-14:30 | Break | ||||
| 14:30-15:45 |
Symposium 7
Evolving Landscape of HR+/HER2- Metastatic Breast Cancer Treatment
|
Panel Discussion 5
Modern Axillary Management in Breast Cancer with Regional Nodal Involvement
|
Education Session 3
Breast Cancer Related Lymphedema: Etiologic Factors and Risk Stratification
|
Junior Doctors Forum
(14:30-15:20)
|
Mini Oral Presentation 4
|
| Break | |||||
|
Junior Doctors Debate
(15:35-17:15)
|
|||||
| 15:45-16:00 | Break | ||||
| 16:00-17:15 |
Symposium 8
De-escalation of Breast Cancer Surgery: What We Know vs. What We Actually Do
|
Symposium 9
Shaping the Future of Breast Cancer Treatment with Antibody Drug Conjugates
|
Education Session 4
Locoregional Management for Lymph Node Positive Breast Cancer
|
Education Session 5
Enhancing and Optimizing Survivorship Throughout Cancer Treatment
|
|
| 17:30-18:00 | |||||
| 18:30~21:00 |
Presidential Dinner
*Invited Only
(Aston House) |
||||
Partner I INTERCOM Convention Services, Inc. (Core PCO)
TOP